ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,390.00
0.08%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Puma Biotechnology Inc (PBYI) Share Price

PBYI Puma Biotechnology Inc

3.6374
0.0774 (2.17%)
08 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Puma Biotechnology Inc NASDAQ:PBYI NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.0774 2.17 3.6374 3.40 3.88 3.61 3.45 3.53 155,195 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 235.64M 21.59M 0.4479 7.86 169.69M
 Type  Size  Price  Time  Units 
 9 1 3.46 23:22:17 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore PBYI News
07/06/202422:37BWPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03/06/202419:33BWPuma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer
02/06/202415:01BWPuma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
28/05/202414:00BWPuma Biotechnology to Join Russell 3000 Index
23/05/202422:15BWPuma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
17/05/202421:43EDGAR2Form 8-K - Current report
02/05/202421:05BWPuma Biotechnology Reports First Quarter Financial Results
Period
Draw mode
Data Downloads for PBYI

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Puma Biotechnology Inc Articles